Related Experiment Videos
A review on thromboprophylaxis in pregnancy
1Department of Obstetrics and Gynaecology, University Malaya Medical Centre, Kuala Lumpur.
The Medical Journal of Malaysia
|May 17, 2002
Abstract:
Thromboembolic disease remains an important cause of maternal mortality worldwide. The risk assessments for prevention of thromboembolism in pregnancy are controversial due to lack of large-scale randomised controlled trials. Unfractionated heparin is at present, the anticoagulant of choice during pregnancy. However, it may be superseded by low-molecular-weight heparin in the near future because of its safety and efficacy.